Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

Comparative statistics by cancer registry

(Karunagappally, India, 1991-1997 cases followed-up until 1999)

Click on cancer site (ICD-10 code) for comparison

Site	ICD-10	No. of cases included	Complete FU		Incomplete FU: loss to FU						% with Complete FU at 5 years	Median FU (in months)
			Alive/dead	At end of FU	No.	%	% lost to FU: years from diagnosis
			No.	%	No.	%	<1	1-3	3-5	>5
C01-02	Tongue	86	84	97.7	2	2.3	1.2	0.0	1.2	0.0	97.7	15.6
C03-06	Oral cavity	123	119	96.7	4	3.3	1.6	0.8	0.8	0.0	96.7	18.7
C12-13	Hypopharynx	33	31	93.9	2	6.1	6.1	0.0	0.0	0.0	93.9	12.6
C15	Oesophagus	106	105	99.1	1	0.9	0.9	0.0	0.0	0.0	99.1	6.5
C16	Stomach	77	77	100.0	0	0.0	0.0	0.0	0.0	0.0	100.0	5.1
C19-20	Rectum	38	38	100.0	0	0.0	0.0	0.0	0.0	0.0	100.0	32.0
C22	Liver	54	53	98.1	1	1.9	1.9	0.0	0.0	0.0	98.1	3.5
C25	Pancreas	41	41	100.0	0	0.0	0.0	0.0	0.0	0.0	100.0	4.0
C32	Larynx	46	45	97.8	1	2.2	0.0	2.2	0.0	0.0	97.8	17.6
C33-34	Lung	220	217	98.6	3	1.4	1.4	0.0	0.0	0.0	98.6	5.2
C44	Other skin	27	25	92.6	2	7.4	3.7	0.0	3.7	0.0	92.6	59.0
C50	Breast	190	188	98.9	2	1.1	0.5	0.0	0.0	0.5	99.5	36.1
C53	Cervix	170	169	99.4	1	0.6	0.0	0.6	0.0	0.0	99.4	38.5
C56	Ovary	35	35	100.0	0	0.0	0.0	0.0	0.0	0.0	100.0	20.3
C61	Prostate	32	29	90.6	3	9.4	6.3	3.1	0.0	0.0	90.6	34.0
C67	Urinary bladder	38	37	97.4	1	2.6	2.6	0.0	0.0	0.0	97.4	18.6
C70-72	Brain & nervous system	46	45	97.8	1	2.2	0.0	2.2	0.0	0.0	97.8	19.9
C73	Thyroid	74	73	98.6	1	1.4	1.4	0.0	0.0	0.0	98.6	57.0
C82-85+C96	Non-Hodgkin lymphoma	69	69	100.0	0	0.0	0.0	0.0	0.0	0.0	100.0	12.1
C90	Multiple myeloma	28	27	96.4	1	3.6	3.6	0.0	0.0	0.0	96.4	17.4
C91	Lymphoid leukaemia	38	38	100.0	0	0.0	0.0	0.0	0.0	0.0	100.0	20.3
C92-94	Myeloid leukaemia	30	30	100.0	0	0.0	0.0	0.0	0.0	0.0	100.0	2.9

Other tables available for this registry:

- Table1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Karunagappally, India, 1991-1997 cases followed-up until 1999)
- Table2a:	Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Karunagappally, India, 1991-1997 cases followed-up until 1999)
- Table3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Karunagappally, India, 1991-1997 cases followed-up until 1999)
- Table4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Karunagappally, India, 1991-1997 cases followed-up until 1999)
- Table5b:	Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Karunagappally, India, 1991-1997)

Registry chapter: